This week in Apple news: anticipated iPhone 17 launch dates, innovative display upgrades, new iOS 26 features, and a sneak peek at the 2026 MacBook Pro. Discover the future of Apple technology!
President Trump has ordered U.S. strikes on Iranian nuclear sites, raising questions about presidential authority and the need for congressional approval. Dive into the legal debates and implications of this controversial decision.
Katie Price's AI-powered digital twin, Jordan, is taking the world by storm, offering users a chance to live out their fantasies through lifelike interactions. Discover the implications of this provocative technology!
Discover the Marshall Tufton, a stylish Bluetooth speaker boasting a powerful woofer and adjustable sound controls. Perfect for music lovers looking for punchy audio, though it lacks some modern features.
In a surprising twist, Samsung is set to launch the ultra-thin Galaxy Z Fold7, measuring just 9mm when folded. This leap in design puts pressure on competitors like Honor and Vivo, who are racing to release their own foldable devices. A recent YouTube leak showcases the non-functional dummy model that mirrors the final design, making the Z Fold7 a formidable contender in the foldable market.
In a stunning development, Sergei Tikhanovsky, husband of Belarusian opposition leader Svetlana Tikhanovskaya, has been released from prison alongside 13 other political prisoners, reuniting with his wife after five years in exile. This unexpected move comes amid diplomatic negotiations involving the US.
The U.S. is facing a significant rise in measles cases, with multiple outbreaks reported across several states, including Texas and Iowa. Health officials warn of the dangers as vaccination rates decline.
In a significant setback for the Republicans' tax and spending cut bill, the Senate parliamentarian ruled that a proposal to shift food stamp costs to states violates Senate rules, jeopardizing potential savings and the bill's future.
A groundbreaking HIV prevention shot, Yeztugo, has been approved by the FDA, offering hope for at-risk individuals with its twice-yearly injections. However, concerns about cost and accessibility remain.
In a stunning development, U.S. B-2 bombers have been deployed in strikes against Iran's nuclear sites, as confirmed by a U.S. official. This escalates tensions in the region significantly.
